• Info
  • Insider Ownership

Insider Trading & Ownership of Mark James Litton

Location
Bothell, WA
Summary
The estimated net worth of Mark James Litton is at least $414,442 dollars as of 05 Jan 2026. Mark James Litton is the President and CEO, Director of Athira Pharma, Inc. and owns shares of LeonaBio, Inc. (LONA) stock worth about $414.4K.
Signature
/s/ Mark Worthington, Attorney-in-Fact on behalf of Mark James Litton
All Insider Reports
All Insider Reports

Notify me when Mark James Litton files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of Mark James Litton

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
LONA, ATHA Athira Pharma, Inc. President and CEO, Director $414,442 -$25,165 -5.7% 31 Dec 2025

Insider Transactions Reported by Mark James Litton:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.